IDC FutureScape Figure

Figure: IDC FutureScape: Worldwide Life Sciences 2023 Top 10 Predictions

Executive Summary

IDC FutureScape Predictions

Summary of External Drivers

Predictions: Impact on Technology Buyers

Prediction 1: By the End of 2024, Transparency Improvements Driven by Drug Serialization and Traceability Mandates Will Translate into 20% Reduction in Revenue Leakage at Life Science Companies Worldwide

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 2: By 2025, 50% of Life Science Organizations Will Adopt Intelligent Tech Platforms to Embrace Sustainability-by-Design Strategies and Track Value Chain Emissions Across Sites, Processes, and Products

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 3: By 2025, 80% of Pharma Will Have Adopted AI-Enabled Pharmacovigilance Solutions with "Human in the Loop" to Avoid "Black Swan Events," Drive Patient Safety, and Support Value-Based Pricing

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 4: By 2025, 60% of Life Science Firms Will Use Health Data Platforms for Physician Engagement and Patient Journey Processes, 65% to Support Regulatory Submissions, and 35% to Support Value-Based Pricing

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 5: By 2026, Investments in Integrated Supply Chain Management Will Enable Half of Global Life Science Manufacturers to Increase Revenue by Avoiding Stockouts of Active Ingredients and Supplies

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 6: By 2026, the Adoption of AI-Based Drug Design by the Life Science Industry Will Grow by 65%, Fueled by a Focus on Precision Medicine and a Fast-Growing Ecosystem of Innovative Tech Start-Ups

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 7: By 2027, Investments in Digital Pathology Multimodal Data Integration Capabilities Will Double to Advance Cancer Diagnostics, Define Composite Biomarkers, and Drive a Precision Medicine Strategy

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 8: By the End of 2027, 95% of Pharma Companies Will Have Established Strategic Partnerships to Access Real-World Data, with 25% Transitioning to the Adoption of Synthetic Data

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 9: Pioneered by the United States, Retail Pharmacies Will Fuel Diversity and Inclusion, Increasing Access to Clinical Trials by 60%, Enabling a Care Anywhere Strategy, and Driving Adoption of CRAACO by 2028

Associated Drivers

IT Impact

Patient Impact

Guidance

Prediction 10: By 2028, 60% of Life Science Organizations Will Have Adopted the Metaverse with Early Adoption for HCP Engagement, Training, and Sales Enablement, with Gradual Adoption in Digital Therapeutics

Associated Drivers

IT Impact

Patient Impact

Guidance

Advice for Technology Buyers

External Drivers: Detail

Storms of Disruption — Accelerating, Interconnected Uncertainty

Cybersecurity and Risk — Scaling and Evolving Threat Environment

Global Supply Shock — Refocusing on Multisource and Resilience

Digital Business — Stepping Stone to the Future Enterprise

Meaningful Intelligence — Differentiated Decision Power

Embracing the Metaverse — New Levels of Immersion

Mainstream ESG — Sustainability Is Measured and Mandatory

Learn More

Related Research